Navigating Systemic Therapy in Advanced Thyroid Carcinoma: From Standard of Care to Personalized Therapy and Beyond

Sarika N Rao1,2, Maria E Cabanillas3

  • 1MedStar Washington Hospital Center, Washington, DC.

Insights

Thyroid cancer outcomes are favorable, but advanced or recurrent cases require targeted therapy. This review discusses when and how to initiate kinase inhibitor treatments for better patient prognosis.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Thyroid cancer generally has a good prognosis with standard treatment, except for anaplastic thyroid cancer.
  • Persistent, recurrent, or metastatic thyroid cancer presents a significant challenge with a poorer prognosis.

Purpose of the Study:

  • To discuss the optimal timing and strategy for initiating targeted therapy in advanced thyroid cancer.
  • To provide guidance on the clinical application of kinase inhibitors for thyroid cancer management.

Main Methods:

  • Review of current clinical practice and emerging data on targeted therapies for thyroid cancer.
  • Discussion of approved kinase inhibitor regimens and those in development.

Main Results:

  • Five drug regimens targeting kinase pathways are currently approved for differentiated, medullary, and anaplastic thyroid cancer.
  • Numerous additional targeted therapy options are under investigation and development.

Conclusions:

  • While standard therapy is effective for most thyroid cancers, targeted therapies are crucial for advanced or refractory disease.
  • Deciding when and how to implement kinase inhibitor therapy remains a key clinical dilemma requiring careful consideration.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.1K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
1.1K
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
1.1K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
446
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K